[Congressional Bills 115th Congress]
[From the U.S. Government Publishing Office]
[S. 1123 Introduced in Senate (IS)]

<DOC>






115th CONGRESS
  1st Session
                                S. 1123

  To reauthorize the Office of National Drug Control Policy, and for 
                            other purposes.


_______________________________________________________________________


                   IN THE SENATE OF THE UNITED STATES

                              May 15, 2017

  Mrs. Shaheen (for herself and Ms. Hassan) introduced the following 
    bill; which was read twice and referred to the Committee on the 
                               Judiciary

_______________________________________________________________________

                                 A BILL


 
  To reauthorize the Office of National Drug Control Policy, and for 
                            other purposes.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SHORT TITLE; TABLE OF CONTENTS.

    (a) Short Title.--This Act may be cited as the ``Office of National 
Drug Control Policy Reauthorization Act of 2017''.
    (b) Table of Contents.--The table of contents for this Act is as 
follows:

Sec. 1. Short title; table of contents.
  TITLE I--ORGANIZATION OF OFFICE OF NATIONAL DRUG CONTROL POLICY AND 
                       ROLES AND RESPONSIBILITIES

Sec. 101. Amendments to definitions.
Sec. 102. Office of National Drug Control Policy.
Sec. 103. Appointment and responsibilities of the Director.
Sec. 104. Coordination with other agencies.
              TITLE II--THE NATIONAL DRUG CONTROL STRATEGY

Sec. 201. Annual preparation and submission of national drug control 
                            strategy.
            TITLE III--HIGH INTENSITY DRUG TRAFFICKING AREAS

Sec. 301. High intensity drug trafficking areas program.
         TITLE IV--DRUG INTERDICTION COORDINATOR AND COMMITTEE

Sec. 401. Drug interdiction coordinator.
 TITLE V--AUTHORIZATION OF APPROPRIATIONS AND EXTENSION OF TERMINATION 
                                  DATE

Sec. 501. Authorization of appropriations.
Sec. 502. Extension of termination date.
  TITLE VI--AMENDMENTS TO THE OFFICE OF NATIONAL DRUG CONTROL POLICY 
                      REAUTHORIZATION ACT OF 2006

Sec. 601. Model Acts.
Sec. 602. Elimination of former reporting requirements.

  TITLE I--ORGANIZATION OF OFFICE OF NATIONAL DRUG CONTROL POLICY AND 
                       ROLES AND RESPONSIBILITIES

SEC. 101. AMENDMENTS TO DEFINITIONS.

    (a) Demand Reduction.--Section 702(1) of the Office of National 
Drug Control Policy Reauthorization Act of 1998 (21 U.S.C. 1701(1)) is 
amended--
            (1) by redesignating subparagraphs (A) through (H) as 
        clauses (i) through (viii), respectively, and adjusting the 
        margins accordingly;
            (2) by redesignating subparagraphs (I) and (J) as clauses 
        (xii) and (xiii), respectively, and adjusting the margins 
        accordingly;
            (3) in the matter preceding clause (i), as so redesignated, 
        by striking ```demand reduction' means'' and all that follows 
        through ``including--'' and inserting the following: ```demand 
        reduction'--
                    ``(A) means any activity conducted by a National 
                Drug Control Program agency, other than an enforcement 
                activity, that is intended to reduce the use of drugs; 
                and
                    ``(B) includes prevention, treatment, and recovery 
                efforts, such as--'';
            (4) by inserting after clause (viii), as so redesignated, 
        the following:
                            ``(ix) screening and brief interventions 
                        for substance use disorders;
                            ``(x) promoting availability of and access 
                        to health care services for the treatment of 
                        substance use disorders;
                            ``(xi) support for long-term recovery from 
                        substance use disorders''; and
            (5) in clause (xiii), as so redesignated, by inserting 
        ``recovery,'' after ``treatment,''.
    (b) Appropriate Congressional Committees.--Section 702(12) of the 
Office of National Drug Control Policy Reauthorization Act of 1998 (21 
U.S.C. 1701(12)) is amended by inserting ``, the Committee on Health, 
Education, Labor, and Pensions'' before ``, the Committee on 
Appropriations''.
    (c) Illicit Drug Use; Illegal Drug Use.--Section 702 of the Office 
of National Drug Control Policy Reauthorization Act of 1998 (21 U.S.C. 
1701) is amended by adding at the end the following:
            ``(14) Illicit drug use; illegal drug use.--The terms 
        `illicit drug use', `illegal drug use', `illegal use of drugs', 
        `illicit use of drugs', `illicit drug', and `illegal drug' 
        include the illegal use of prescription drugs.''.

SEC. 102. OFFICE OF NATIONAL DRUG CONTROL POLICY.

    (a) Amendments.--Section 703(b) of the Office of National Drug 
Control Policy Reauthorization Act of 1998 (21 U.S.C. 1702(b)) is 
amended--
            (1) in the heading, by striking ``and Deputy Directors'';
            (2) by striking paragraph (2), and inserting the following:
            ``(2) Responsibilities.--The Director, and such members of 
        the Office of National Drug Control Policy staff as designated 
        by the Director, shall be responsible for demand reduction 
        activities, supply reduction activities, and for State, local, 
        and tribal affairs.''; and
            (3) by amending paragraph (3) to read as follows:
            ``(3) Other deputy directors.--There shall be a Deputy 
        Director for Demand Reduction, a Deputy Director for Supply 
        Reduction, and a Deputy Director for State, Local, and Tribal 
        Affairs.''.
    (b) Effective Date.--The amendments made by subsection (a) shall 
take effect on October 1, 2017.

SEC. 103. APPOINTMENT AND RESPONSIBILITIES OF THE DIRECTOR.

    (a) Appointment.--
            (1) Amendments.--Section 704 of the Office of National Drug 
        Control Policy Reauthorization Act of 1998 (21 U.S.C. 1703) is 
        amended--
                    (A) in the heading, by striking ``and Deputy 
                Directors''; and
                    (B) in subsection (a)--
                            (i) by amending paragraph (1) to read as 
                        follows:
            ``(1) Director.--The Director shall be appointed by the 
        President, by and with the advice and consent of the Senate, 
        and shall serve at the pleasure of the President.'';
                            (ii) by striking paragraphs (2) and (3);
                            (iii) by redesignating paragraphs (4) and 
                        (5) as paragraphs (2) and (3), respectively; 
                        and
                            (iv) in paragraph (2), as so redesignated, 
                        by striking ``or a Deputy Director''.
            (2) Effective date.--The amendments made by paragraph (1) 
        shall take effect on January 20, 2018.
    (b) Responsibilities.--Subsection 704(b) of the Office of National 
Drug Control Policy Reauthorization Act of 1998 (21 U.S.C. 1703(b)) is 
amended--
            (1) in paragraph (13)(E), by striking ``treatment and 
        prevention'' and inserting ``treatment, prevention, and 
        recovery support'';
            (2) in paragraph (15), by striking ``prevention and drug 
        treatment'' and inserting ``prevention, drug treatment, and 
        recovery'';
            (3) in paragraph (18), by adding ``and'' after the 
        semicolon;
            (4) in paragraph (19), by striking ``; and'' and inserting 
        a period; and
            (5) by striking paragraph (20).
    (c) Fund Control Notices.--Section 704(f) of the Office of National 
Drug Control Policy Reauthorization Act of 1998 (21 U.S.C. 1703(f)) is 
amended--
            (1) in the first paragraph (5), in subparagraph (A), by 
        inserting ``or statute'' after ``appropriation'';
            (2) by striking the second paragraph (4); and
            (3) by striking the second paragraph (5).

SEC. 104. COORDINATION WITH OTHER AGENCIES.

    Section 705(d) of the Office of National Drug Control Policy 
Reauthorization Act of 1998 (21 U.S.C. 1704(d)) is amended--
            (1) in the header by striking ``Expended'' and inserting 
        ``Obligated''; and
            (2) in paragraph (A), by striking ``(A) require'' and 
        inserting ``(1) require''.

SEC. 105. REPORT ON INTERNET PURCHASING OF SYNTHETIC DRUGS AND 
              PRECURSOR CHEMICALS.

    Not later than 180 days after the date of enactment of this Act, 
the Director of National Drug Control Policy, in consultation with the 
Attorney General and the Administrator of the Drug Enforcement 
Administration, shall submit to Congress a report on Internet 
purchasing of synthetic drugs and precursor chemicals that includes--
            (1) how purchases of synthetic drugs and precursor 
        chemicals are conducted on the open Internet and the dark web;
            (2) the scale of the problem described in paragraph (1);
            (3) the country of origin of the relevant Web sites, 
        manufacturers, and distributors;
            (4) measures that can be taken to eliminate the sale of 
        synthetic drugs and precursor chemicals over the Internet; and
            (5) any recommendations for legislation necessary to 
        eliminate the sale of synthetic drugs and precursor chemicals 
        over the Internet.

              TITLE II--THE NATIONAL DRUG CONTROL STRATEGY

SEC. 201. ANNUAL PREPARATION AND SUBMISSION OF NATIONAL DRUG CONTROL 
              STRATEGY.

    Section 706(a) of the Office of National Drug Control Policy 
Reauthorization Act of 1998 (21 U.S.C. 1705(a)) is amended--
            (1) in paragraph (1) by inserting before the period ``, and 
        by promoting prevention, early intervention, treatment, and 
        recovery support for individuals with substance use 
        disorders'';
            (2) in paragraph (2)(A)--
                    (A) in clause (i), by inserting ``, including the 
                misuse of prescription drugs,'' before ``and the'';
                    (B) by striking clause (ix); and
                    (C) by redesignating clauses (x) through (xiv) and 
                clauses (ix) through (xiii), respectively; and
            (3) in paragraph (3)--
                    (A) in subparagraph (B), by inserting ``and'' at 
                the end;
                    (B) in subparagraph (C), by striking ``; and'' and 
                inserting a period; and
                    (C) by striking subparagraph (D).

            TITLE III--HIGH INTENSITY DRUG TRAFFICKING AREAS

SEC. 301. HIGH INTENSITY DRUG TRAFFICKING AREAS PROGRAM.

    Section 707 of the Office of National Drug Control Policy 
Reauthorization Act of 1998 (21 U.S.C. 1706) is amended--
            (1) by striking subsections (k), (l), and (m) and inserting 
        the following:
    ``(k) Evaluation of HIDTA as Part of the National Drug Control 
Strategy.--
            ``(1) Report.--The Director shall, as part of the National 
        Drug Control Strategy and after consulting with the Executive 
        Boards of each designated high intensity drug trafficking area, 
        submit a report to Congress that describes, for each designated 
        high intensity drug trafficking area--
                    ``(A) the specific purposes for the high intensity 
                drug trafficking area;
                    ``(B) the specific long-term and short-term goals 
                and objectives for the high intensity drug trafficking 
                area;
                    ``(C) the measurements that will be used to 
                evaluate the performance of the high intensity drug 
                trafficking area in achieving the long-term and short-
                term goals;
                    ``(D) the reporting requirements needed, if 
                appropriate, to evaluate the performance of the high 
                intensity drug trafficking area in achieving the long- 
                and short-term goals; and
                    ``(E) an evaluation of the performance of the high 
                intensity drug trafficking area in accomplishing the 
                specific long-term and short-term goals and objectives 
                identified under subparagraph (B).
            ``(2) Assessment of drug enforcement task forces in high 
        intensity drug trafficking areas.--The Director, as part of the 
        report required under paragraph (1), shall--
                    ``(A) assess the number and operation of all 
                federally funded drug enforcement task forces within 
                each high intensity drug trafficking area; and
                    ``(B) describe--
                            ``(i) each Federal, State, local, and 
                        tribal drug enforcement task force operating in 
                        the high intensity drug trafficking area;
                            ``(ii) how such task forces coordinate with 
                        each other, with any high intensity drug 
                        trafficking area task force, and with 
                        investigations receiving funds from the 
                        Organized Crime and Drug Enforcement Task 
                        Force;
                            ``(iii) what steps, if any, each such task 
                        force takes to share information regarding drug 
                        trafficking and drug production with other 
                        federally funded drug enforcement task forces 
                        in the high intensity drug trafficking area;
                            ``(iv) the role of the high intensity drug 
                        trafficking area in coordinating the sharing of 
                        such information among task forces;
                            ``(v) the nature and extent of cooperation 
                        by each Federal, State, local, and tribal 
                        participant in ensuring that such information 
                        is shared among law enforcement agencies and 
                        with the high intensity drug trafficking area;
                            ``(vi) the nature and extent to which 
                        information sharing and enforcement activities 
                        are coordinated with joint terrorism task 
                        forces in the high intensity drug trafficking 
                        area; and
                            ``(vii) any recommendations for measures 
                        needed, if appropriate, to ensure that task 
                        force resources are utilized efficiently and 
                        effectively to reduce the availability of 
                        illegal drugs in the high intensity drug 
                        trafficking areas.
            ``(3) Assessment of law enforcement intelligence sharing in 
        high intensity drug trafficking areas program.--The Director, 
        as part of the report required under paragraph (1), shall--
                    ``(A) evaluate existing and planned law enforcement 
                intelligence systems supported by each high intensity 
                drug trafficking area, or utilized by task forces 
                receiving any funding under the Program, including the 
                extent to which such systems ensure access and 
                availability of law enforcement intelligence to 
                Federal, State, local, and tribal law enforcement 
                agencies within the high intensity drug trafficking 
                area and outside of it;
                    ``(B) describe the extent to which Federal, State, 
                local, and tribal law enforcement agencies 
                participating in each high intensity drug trafficking 
                area are sharing law enforcement intelligence 
                information to assess current drug trafficking threats 
                and design appropriate enforcement strategies; and
                    ``(C) describe the measures needed, if appropriate, 
                to improve effective sharing of information and law 
                enforcement intelligence regarding drug trafficking and 
                drug production among Federal, State, local, and tribal 
                law enforcement participating in a high intensity drug 
                trafficking area, and between such agencies and similar 
                agencies outside the high intensity drug trafficking 
                area.'';
            (2) by redesignating subsections (n), (o), (p), and (q) as 
        subsections (l), (m), (n), and (o), respectively; and
            (3) by amending subsection (n), as so redesignated, to read 
        as follows:
    ``(n) Authorization of Appropriations.--There is authorized to be 
appropriated to the Office of National Drug Control Policy $290,000,000 
for fiscal year 2018 and such sums as are necessary to carry out this 
section for each of fiscal years 2019 through 2023.''.

         TITLE IV--DRUG INTERDICTION COORDINATOR AND COMMITTEE

SEC. 401. DRUG INTERDICTION COORDINATOR.

    Section 711 of the Office of National Drug Control Policy 
Reauthorization Act of 1998 (21 U.S.C. 1710) is amended--
            (1) in subsection (a)--
                    (A) in paragraph (2)--
                            (i) in subparagraph (B)--
                                    (I) by striking ``on or before 
                                March 1 of each year and'';
                                    (II) by striking ``Command and 
                                Control'' and inserting 
                                ``Coordination''; and
                                    (III) by inserting ``and revising 
                                the plan as necessary on or before 
                                March 1 of each year'' before the 
                                semicolon at the end; and
                            (ii) in subparagraph (D), by striking 
                        ``Command and Control'' and inserting 
                        ``Coordination'';
                    (B) in paragraph (3), by striking ``to the Office 
                of Supply Reduction for that purpose'' and inserting 
                ``to the Office to assist the United States 
                Interdiction Coordinator in carrying out the 
                responsibilities described in paragraph (2)''; and
                    (C) in paragraph (4)--
                            (i) by striking ``Command and Control'' 
                        each time that term appears and inserting 
                        ``Coordination'';
                            (ii) in subparagraph (A)(iii), by striking 
                        ``required'' and inserting ``that will be 
                        used''; and
                            (iii) in subparagraph (D), by striking 
                        ``include'' and all that follows through the 
                        period at the end and inserting ``a copy of the 
                        current National Interdiction Coordination Plan 
                        and the most recent Interdiction Performance 
                        Assessment.''; and
            (2) in subsection (b)(1)(B)--
                    (A) by striking ``annual'' and inserting 
                ``revised''; and
                    (B) by striking ``Command and Control'' and 
                inserting ``Coordination''.

 TITLE V--AUTHORIZATION OF APPROPRIATIONS AND EXTENSION OF TERMINATION 
                                  DATE

SEC. 501. AUTHORIZATION OF APPROPRIATIONS.

    Section 714 of the Office of National Drug Control Policy 
Reauthorization Act of 1998 (21 U.S.C. 1711) is amended by striking 
``2006 through 2010'' and inserting ``2018 through 2023''.

SEC. 502. EXTENSION OF TERMINATION DATE.

    Section 715(a) of the Office of National Drug Control Policy 
Reauthorization Act of 1998 (21 U.S.C. 1712(a)) is amended by striking 
``2010'' and inserting ``2023''.

  TITLE VI--AMENDMENTS TO THE OFFICE OF NATIONAL DRUG CONTROL POLICY 
                      REAUTHORIZATION ACT OF 2006

SEC. 601. MODEL ACTS.

    Section 1105 of the Office of National Drug Control Policy 
Reauthorization Act of 2006 (21 U.S.C. 1701 note) is amended by 
striking subsection (b) and inserting the following:
    ``(b) Authorization of Appropriations.--There is authorized to be 
appropriated to carry out this subsection such sums as are necessary 
for each of fiscal years 2018 through 2023.''.

SEC. 602. ELIMINATION OF FORMER REPORTING REQUIREMENTS.

    The Office of National Drug Control Policy Reauthorization Act of 
2006 (Public Law 109-469; 120 Stat. 3502) is amended--
            (1) in section 802 (120 Stat. 3535)--
                    (A) in subsection (a), by striking ``(a) In 
                General.--''; and
                    (B) by striking subsection (b) (21 U.S.C. 1532 
                note); and
            (2) by repealing sections 1103, 1104, 1109, 1111, and 1114 
        (120 Stat. 3540, 3543, and 3544).
                                 <all>